Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
178,31-08-2022,odorkor,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, B33.0 [Epidemic myalgia]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,31-08-2022,31-08-2022,,,20,OPD,
362,31-08-2022,Scc,73 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"H40.59 [Ocular hypertension, unspecified eye]  ==> NEW, I10. [Essential (primary) hypertension]  ==> NEW",No,Non-Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",Pensioner,,31-08-2022,31-08-2022,,,20,OPD,
516,31-08-2022,ABOSSEY OKAI,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,31-08-2022,31-08-2022,,,75,OPD,
633,30-08-2022,kasoa,55 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 20 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 20 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,30-08-2022,30-08-2022,,,0,OPD,
758,30-08-2022,TUBA ROAD,71 Year(s),Male,,,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,I11.0 [Hypertensive heart disease with (congestive) heart failure]  ==> NEW,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], FUROSEMIDE INJECTION 20MG[ FUROSEMIDE | 10MG/ML IN 2ML | Injection ]",,,30-08-2022,30-08-2022,,,30,OPD,
807,30-08-2022,NEW WEIJA ,69 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.49 [Diabetes mellitus due to underlying condition with other diabetic neurological complication]  ==> NEW,"A01.4 [Paratyphoid fever, unspecified]  ==> NEW",No,Insured,"CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BDS |  For 7 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",pension,,30-08-2022,30-08-2022,,,10,OPD,
909,30-08-2022,MALLAM ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]",,,,30-08-2022,30-08-2022,,,10,OPD,
930,30-08-2022,KASOA,75 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,,,30-08-2022,30-08-2022,,,75,OPD,
953,30-08-2022,ABLEKUMA ,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,B50.8 [Other severe and complicated Plasmodium falciparum malaria]  ==> OLD,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,30-08-2022,30-08-2022,,,10,OPD,
973,30-08-2022,MCCARTHY,83 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,,,,,30-08-2022,30-08-2022,,,10,OPD,
1184,30-08-2022,GBAWE OLD MARKET,76 Year(s),Female,,,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",,No,Non-Insured,"AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 3 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | TDS |  For 5 Days  ]","AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ]",Unemployed,,30-08-2022,30-08-2022,,,120,OPD,
1216,29-08-2022,gbawe,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-08-2022,29-08-2022,,,10,OPD,
1217,29-08-2022,WEIJA- CHOICE,50 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-08-2022,29-08-2022,,,10,OPD,
1236,29-08-2022,MALLAM,35 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-08-2022,29-08-2022,,,10,OPD,
1303,29-08-2022,FADAMA,71 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Non-Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",Pensioner,,29-08-2022,29-08-2022,,,70,OPD,
1338,29-08-2022,AYIGBE TOWN,35 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",,,29-08-2022,29-08-2022,,,60,OPD,
1362,29-08-2022,"KASOA
MILLINIUM CITY",66 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,DIABETIC MACULOPATHY ,"E08.37X3 [Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, bilateral]  ==> NEW","H25.9 [Senile cataract, unspecified]  ==> NEW",No,Non-Insured,"ACETAZOLAMIDE TABLET 250MG[ ACETAZOLAMIDE | 250MG | Tablet | Daily |  For 0 Days  ], II CARE CAPSULES[ II CARE |  | Capsule | Daily |  For 0 Days  ]",,Unemployed,,29-08-2022,29-08-2022,,,10,OPD,
1610,29-08-2022,gbawe,37 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.8 [Non-insulin-dependent diabetes mellitus: With unspecified complications]  ==> NEW,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,29-08-2022,29-08-2022,,,25,OPD,
1856,29-08-2022,ABLEKUMAH-NIC,51 Year(s),Male,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TID |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Mason,,29-08-2022,29-08-2022,,,50,OPD,
1859,29-08-2022,SOWUTOUM-DEEP LIFE,80 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.641 [Other specified diabetes mellitus with hypoglycemia with coma]  ==> NEW,,No,Insured,"CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BDS |  For 7 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], DEXTROSE INFUSION 10%[ DEXTROSE | 10% 500ML | Infusion | BDS |  For 1 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 10 Days  ]","CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], DEXTROSE INFUSION 10%[ DEXTROSE | 10% 500ML | Infusion ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",Pensioner,,29-08-2022,29-08-2022,,,305,OPD,
1901,28-08-2022,WEIJA ,60 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ARTEMETHER+LUMIFANTRINE (6[ COARTEM | 80/480MG | Tablet | BDS |  For 3 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | TID |  For 5 Days  ]",,driver,,28-08-2022,28-08-2022,,,50,OPD,
1909,28-08-2022,LAPAZ ,39 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,28-08-2022,28-08-2022,,,50,OPD,
2035,27-08-2022,top base,78 Year(s),Female,,,,No Outcome,NA ,E10.649 [Type 1 diabetes mellitus with hypoglycemia without coma]  ==> NEW,I16.0 [Hypertensive urgency]  ==> NEW,No,Insured,LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 10 Days  ],LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ],,,27-08-2022,27-08-2022,,,50,OPD,
2042,27-08-2022,ODORKOR,48 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,"B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW",No,Non-Insured,"METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 10 Days  ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BDS |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ]","METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",TRADER,,27-08-2022,27-08-2022,,,50,OPD,
2165,26-08-2022,NEW BORTIANOR,71 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, G20. [Parkinson disease]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]",,,,26-08-2022,26-08-2022,,,10,OPD,
2185,26-08-2022,"APLAKU
OPPSITE KINGS UNIVERSITY",74 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,"L97. [Ulcer of lower limb, not elsewhere classified]  ==> NEW, I10. [Essential (primary) hypertension]  ==> NEW",No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 14 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ]",,,,26-08-2022,26-08-2022,,,60,OPD,
2474,26-08-2022,"ABLEKUMA, FUNMILK",78 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],TRADER,,26-08-2022,26-08-2022,,,130,OPD,
2582,25-08-2022,"NYAMESTE 
LAPAZ",33 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,25-08-2022,25-08-2022,,,20,OPD,
2588,25-08-2022,malla,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,25-08-2022,25-08-2022,,,20,OPD,
2604,25-08-2022,BORTIANOR ,54 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,25-08-2022,25-08-2022,,,20,OPD,
2619,25-08-2022,BUBIASHIE-COMTROL,62 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,25-08-2022,25-08-2022,,,20,OPD,19261/20
2691,25-08-2022,NEW WEIJA ,63 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,K29.21 [Alcoholic gastritis with bleeding]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 14 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BDS |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ]",,,25-08-2022,25-08-2022,,,50,OPD,
3020,25-08-2022,"GBAWE , TOP BASE ",67 Year(s),Female,,,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,A40.8 [Other streptococcal sepsis]  ==> NEW,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 30 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], METRONIDAOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TDS |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,25-08-2022,25-08-2022,,,30,OPD,
3249,24-08-2022,SCC AZUMA,64 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]",,CLERGY,,24-08-2022,24-08-2022,,,90,OPD,
3372,24-08-2022,MADINA,48 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,24-08-2022,24-08-2022,,,20,OPD,
3569,24-08-2022,KOKROBITEY,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.21 [Type 2 diabetes mellitus with diabetic nephropathy]  ==> NEW,"J39.9 [Disease of upper respiratory tract, unspecified]  ==> NEW",No,Insured,"AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet | OD |  For 3 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ], CARBOCISTEINE  PAEDIATRIC SYRUP[ CARBOCISTEINE  PAEDIATRIC |  2% 125MG/5ML | Syrup | TID |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], CARBOCISTEINE  PAEDIATRIC SYRUP[ CARBOCISTEINE  PAEDIATRIC |  2% 125MG/5ML | Syrup ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,24-08-2022,24-08-2022,,,20,OPD,
3852,23-08-2022,tetegu,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,K29.1 [Other acute gastritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], MAGNESIUM TRISILICATE+ALUMINIUM HYDROXIDE MIXTURE[ MAGNESIUM TRISILICATE+AL(OH) | 200ML | Suspension | BDS |  For 5 Days  ]",,,,23-08-2022,23-08-2022,,,10,OPD,
3873,23-08-2022,"TUBA, BORTIANOR HILLS",86 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]",,,,23-08-2022,23-08-2022,,,25,OPD,
3939,23-08-2022,RUSSIA,50 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,N34.2 [Other urethritis]  ==> NEW,No,Insured,"PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet | OD |  For 30 Days  ]",,,,23-08-2022,23-08-2022,,,20,OPD,
4454,23-08-2022,"TAIFA, NORWAY",68 Year(s),Male,,,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,,,,,23-08-2022,23-08-2022,,,70,OPD,
4548,22-08-2022,mallam bola raod,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> OLD, N34.1 [Nonspecific urethritis]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 60 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Nocte |  For 10 Days  ]",,,,22-08-2022,22-08-2022,,,20,OPD,
4554,22-08-2022,kasoa,47 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 60 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,22-08-2022,22-08-2022,,,20,OPD,
4555,22-08-2022,mallam,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,22-08-2022,22-08-2022,,,20,OPD,
4556,22-08-2022,tetegu,45 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",,,22-08-2022,22-08-2022,,,20,OPD,
4558,22-08-2022,AWOSHIE,44 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,22-08-2022,22-08-2022,,,20,OPD,
4733,22-08-2022,kwashieman,47 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-08-2022,22-08-2022,,,0,OPD,
4755,22-08-2022,kasoa,59 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,22-08-2022,22-08-2022,,,0,OPD,
4791,22-08-2022,"GBAWE
BULEMIN",29 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-08-2022,22-08-2022,,,10,OPD,
5464,20-08-2022,WEIJA OLD BARRIER NEAR KINGS UNIVERSITY ,70 Year(s),Male,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, N34.1 [Nonspecific urethritis]  ==> NEW",No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | PRN |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 30 Days  ], CEFIXIME TABLET 200MG[ CEFIXIME | 200MG | Tablet | BID |  For 7 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CEFIXIME TABLET 200MG[ CEFIXIME | 200MG | Tablet ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",,,20-08-2022,20-08-2022,,,0,OPD,
5540,19-08-2022,dankuman,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-08-2022,19-08-2022,,,20,OPD,
5572,19-08-2022,"SCC, BROADCASTING",53 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ]",,,,19-08-2022,19-08-2022,,,20,OPD,
5587,19-08-2022,sowutuom,47 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,19-08-2022,19-08-2022,,,30,OPD,
5598,19-08-2022,"KASOA
OPEIKUMA",56 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,"L97. [Ulcer of lower limb, not elsewhere classified]  ==> NEW, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 10 Days  ]","AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,19-08-2022,19-08-2022,,,10,OPD,
5608,19-08-2022,ABLEKUAMH-NIC,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.01 [Diabetes mellitus due to underlying condition with hyperosmolarity with coma]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> OLD, N34.1 [Nonspecific urethritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",,,19-08-2022,19-08-2022,,,20,OPD,
5622,19-08-2022,ABLEKUMA   AGAPE,76 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 10 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 10 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ]",,,,19-08-2022,19-08-2022,,,0,OPD,
5713,19-08-2022,KASOA ,40 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",TRADER,,19-08-2022,19-08-2022,,,60,OPD,
5853,19-08-2022,"GBAWE , CP ",62 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, A01.09 [Typhoid fever with other complications]  ==> NEW, M79.2 [Neuralgia and neuritis, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",TRADER,,19-08-2022,19-08-2022,,,20,OPD,
6031,18-08-2022,"mallam 
dc",80 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,18-08-2022,18-08-2022,,,20,OPD,
6213,18-08-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet | OD |  For 14 Days  ]",,,,18-08-2022,18-08-2022,,,20,OPD,
6247,18-08-2022,new bortianor,70 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ]",,,,18-08-2022,18-08-2022,,,20,OPD,
6286,18-08-2022,"SWEDRU, YAABAMU",84 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,18-08-2022,18-08-2022,,,50,OPD,
6362,18-08-2022,weija new twon,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,18-08-2022,18-08-2022,,,20,OPD,
6409,18-08-2022,ABLEKUMAH-AGAPE,56 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, L03.115 [Cellulitis of right lower limb]  ==> NEW",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Daily |  For 1 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]",,,,18-08-2022,18-08-2022,,,20,OPD,MR-10A-G5-230
6623,18-08-2022,WEIJA OLD BARRIER NEAR KINGS UNIVERSITY ,70 Year(s),Male,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METRONIDAOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,,,18-08-2022,18-08-2022,,,50,OPD,
6625,18-08-2022,SOUTH MCCATHY ,62 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BDS |  For 10 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BID |  For 14 Days  ], NUGEL SUSPENSION [ NUGEL  | 200ML | Suspension | TDS |  For 14 Days  ]","CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE NASAL DROP[ SALINE | 0.9% 10ML | Drops ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL SUSPENSION [ NUGEL  | 200ML | Suspension ]",Unemployed,,18-08-2022,18-08-2022,,,50,OPD,
6636,17-08-2022,weija ,44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"M43.02 [Spondylolysis, cervical region]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 10 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,17-08-2022,17-08-2022,,,20,OPD,
6707,17-08-2022,KASOA-OCOLOMBA,55 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | OD |  For 14 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ]",,,17-08-2022,17-08-2022,,,10,OPD,
6830,17-08-2022,gbawe,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,17-08-2022,17-08-2022,,,10,OPD,
7373,16-08-2022,"Gbawe 
Gonse",84 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,16-08-2022,16-08-2022,,,30,OPD,
7380,16-08-2022,SOWUTUOM,64 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 3 Days  ], HYDROCORTISONE INJECTION 100MG[ HYDROCORTISONE | 100MG | Injection | Stat |  For 1 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Daily |  For 7 Days  ]","ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ], HYDROCORTISONE INJECTION 100MG[ HYDROCORTISONE | 100MG | Injection ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",,,16-08-2022,16-08-2022,,,60,OPD,
7381,16-08-2022,santa maria-drug store,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,J00. [Acute nasopharyngitis [common cold]]  ==> NEW,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,16-08-2022,16-08-2022,,,25,OPD,
7382,16-08-2022,agape down,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | Nocte |  For 5 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,16-08-2022,16-08-2022,,,10,OPD,
7384,16-08-2022,gbawe,64 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,16-08-2022,16-08-2022,,,20,OPD,
7387,16-08-2022,odorkor,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-08-2022,16-08-2022,,,20,OPD,
7390,16-08-2022,gbawe top base,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 2 Days  ]","RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,16-08-2022,16-08-2022,,,20,OPD,
7430,16-08-2022,"ODORKOR
ST ANTHONY",76 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K25.9 [Gastric ulcer: Unspecified as acute or chronic, without haemorrhage or perforation]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ]",,,16-08-2022,16-08-2022,,,20,OPD,
7451,16-08-2022,ABLEKUMA FAN MILK,76 Year(s),Female,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,16-08-2022,16-08-2022,,,10,OPD,
7503,16-08-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 10 Days  ]","AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",,,16-08-2022,16-08-2022,,,10,OPD,
7508,16-08-2022,SANTA MARIA-AU AKU,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",TRADER,,16-08-2022,16-08-2022,,,50,OPD,20029/17 MR-5A-D4-123
7528,16-08-2022,GBAWE,63 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> NEW, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> NEW",No,Insured,,,,,16-08-2022,16-08-2022,,,10,OPD,
7585,16-08-2022,"APLAKU
OPPSITE KINGS UNIVERSITY",74 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 3 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 3 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 10 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | OD |  For 1 Days  ]","CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ]",,,16-08-2022,16-08-2022,,,110,OPD,
7644,16-08-2022,ablekuma,70 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",Pensioner,,16-08-2022,16-08-2022,,,10,OPD,
7955,16-08-2022,ABOSSEY OKAI,89 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,M79.7 [Fibromyalgia]  ==> NEW,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-08-2022,16-08-2022,,,60,OPD,
8015,16-08-2022,JAMES TOWN CHOCO,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection | TDS |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-08-2022,16-08-2022,,,85,OPD,
8024,15-08-2022,mallam,77 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,15-08-2022,15-08-2022,,,20,OPD,
8025,15-08-2022,awoshie,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,15-08-2022,15-08-2022,,,20,OPD,
8026,15-08-2022,new gbawe,83 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","NAT B CAPSULES[ NAT B |  | Capsule ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,15-08-2022,15-08-2022,,,10,OPD,
8029,15-08-2022,kasoa,32 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,15-08-2022,15-08-2022,,,20,OPD,
8032,15-08-2022,"new bortianor ,broadcasting",74 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, B83.8 [Other specified helminthiases]  ==> NEW, K21.9 [Gastro-oesophageal reflux disease without oesophagitis]  ==> NEW",No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 3 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,15-08-2022,15-08-2022,,,20,OPD,
8033,15-08-2022,scc,60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,15-08-2022,15-08-2022,,,10,OPD,
8097,15-08-2022,GBAWE ,34 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.3293 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral]  ==> NEW",,No,Insured,,,,,15-08-2022,15-08-2022,,,10,OPD,
8118,15-08-2022,kasoa,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG |  | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG |  | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG |  | OD |  For 90 Days  ]",,,,15-08-2022,15-08-2022,,,20,OPD,
8120,15-08-2022,"AWOSHIE, A-LANG",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,15-08-2022,15-08-2022,,,20,OPD,
8178,15-08-2022,WEIJA,58 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,L03.115 [Cellulitis of right lower limb]  ==> NEW,No,Non-Insured,,,Unemployed,,15-08-2022,15-08-2022,,,90,OPD,
8194,15-08-2022,south mc carthy,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,15-08-2022,15-08-2022,,,20,OPD,
8212,15-08-2022,ABLEKUMAH,45 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW",No,Insured,"RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ]","RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ]",,,15-08-2022,15-08-2022,,,20,OPD,
8232,15-08-2022,WEIJA,58 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Non-Insured,,,Unemployed,,15-08-2022,15-08-2022,,,95,OPD,
8278,15-08-2022,"KASOA
MILLINIUM CITY",66 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,DIABETIC MACULOPATHY AND EDEMA ,"E08.37X3 [Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, bilateral]  ==> NEW","H25.9 [Senile cataract, unspecified]  ==> NEW",No,Non-Insured,"II CARE CAPSULES[ II CARE |  | Capsule | Daily |  For 30 Days  ], NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | TID |  For 30 Days  ], ACETAZOLAMIDE TABLET 250MG[ ACETAZOLAMIDE | 250MG | Tablet | Daily |  For 30 Days  ]",,Unemployed,,15-08-2022,15-08-2022,,,10,OPD,
8294,15-08-2022,AMANFROM - GALILIA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,15-08-2022,15-08-2022,,,20,OPD,
8724,15-08-2022,SOWUTUOM ,70 Year(s),Female,,,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,15-08-2022,15-08-2022,,,50,OPD,
8787,14-08-2022,KWASHIEMAN HONKON ,49 Year(s),Female,,,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,14-08-2022,14-08-2022,,,110,OPD,
8920,13-08-2022,"APLAKU
OPPSITE KINGS UNIVERSITY",74 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QDS |  For 2 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 2 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,13-08-2022,13-08-2022,,,50,OPD,
8947,13-08-2022,KOKROBITE ,45 Year(s),Male,,,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TID |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",BUSINESS PERSON,,13-08-2022,13-08-2022,,,50,OPD,
8971,12-08-2022,ABOSSEY OKAI-ZONGO,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Pensioner,,12-08-2022,12-08-2022,,,10,OPD,
8990,12-08-2022,GBAWE TELECOM,50 Year(s),Female,,,,No Outcome,NA ,E11.649 [Type 2 diabetes mellitus with hypoglycemia without coma]  ==> NEW,,No,Insured,,,,,12-08-2022,12-08-2022,,,0,OPD,
9063,12-08-2022,kasoa officia twon,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], GILOBA[ GILOBA | 40MG | Capsule | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GILOBA[ GILOBA | 40MG | Capsule ]",,,12-08-2022,12-08-2022,,,20,OPD,
9263,12-08-2022,SAKAMAN ,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",,No,Non-Insured,"DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ], GILOBA[ GILOBA | 40MG | Capsule | Daily |  For 14 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], GILOBA[ GILOBA | 40MG | Capsule ], NAT B CAPSULES[ NAT B |  | Capsule ]",TRADER,,12-08-2022,12-08-2022,,,60,OPD,
9467,11-08-2022,"BLOCK FACTORY , WEIJA ",30 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet ]",Para Professional,,11-08-2022,11-08-2022,,,20,OPD,
9477,11-08-2022,bubiashie,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ]",,,11-08-2022,11-08-2022,,,10,OPD,
9567,11-08-2022,ANYAA PALAS TOWN,63 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I64. [Stroke, not specified as haemorrhage or infarction]  ==> OLD, M79.7 [Fibromyalgia]  ==> NEW",No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | TID |  For 7 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,11-08-2022,11-08-2022,,,20,OPD,
9786,11-08-2022,new weija,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Non-Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,11-08-2022,11-08-2022,,,0,OPD,
10057,11-08-2022,KOKROBITE ,45 Year(s),Male,,,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TID |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",BUSINESS PERSON,,11-08-2022,11-08-2022,,,110,OPD,
10076,10-08-2022,WEIJA,46 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",,,10-08-2022,10-08-2022,,,20,OPD,
10097,10-08-2022,MALLAM-MASALACHI,66 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, L02.219 [Cutaneous abscess of trunk, unspecified]  ==> NEW",No,Insured,GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ],GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ],,,10-08-2022,10-08-2022,,,30,OPD,
10165,10-08-2022,Weija water works ,59 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ], GILOBA[ GILOBA | 40MG | Capsule | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], GILOBA[ GILOBA | 40MG | Capsule ]",,,10-08-2022,10-08-2022,,,20,OPD,
10175,10-08-2022,"Weija , ZONGO",85 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], NAT B CAPSULES[ NAT B |  | Capsule ]",TRADER,,10-08-2022,10-08-2022,,,20,OPD,
10326,10-08-2022,"AGAPE
CONTAINER",70 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> NEW, M79.7 [Fibromyalgia]  ==> NEW, R63.0 [Anorexia]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Mane |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 1 Days  ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet | Daily |  For 15 Days  ]",,,,10-08-2022,10-08-2022,,,20,OPD,
10505,10-08-2022,broadcasting,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I67.9 [Cerebrovascular disease, unspecified]  ==> NEW",No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,10-08-2022,10-08-2022,,,10,OPD,
10677,09-08-2022,new bortianor,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, R73.9 [Hyperglycaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,09-08-2022,09-08-2022,,,20,OPD,
10678,09-08-2022,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | PRN |  For 10 Days  ]",,,,09-08-2022,09-08-2022,,,20,OPD,
10715,09-08-2022,TETEGU-INSIDE,76 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 5 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,09-08-2022,09-08-2022,,,60,OPD,47/22
10754,09-08-2022,TETEGU,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, H81.8X9 [Other disorders of vestibular function, unspecified ear]  ==> NEW",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], STUGERON TABLET 25MG[  | 25MG | Tablet | BID |  For 5 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], STUGERON TABLET 25MG[  | 25MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,09-08-2022,09-08-2022,,,10,OPD,
10755,09-08-2022,santa maria,90 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]",,,,09-08-2022,09-08-2022,,,10,OPD,
10759,09-08-2022,MALLAM ,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,09-08-2022,09-08-2022,,,20,OPD,
10770,09-08-2022,"kasoa,post office",61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GILOBA[ GILOBA | 40MG | Capsule | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GILOBA[ GILOBA | 40MG | Capsule ]",,,09-08-2022,09-08-2022,,,10,OPD,
10904,09-08-2022,Amasaman,65 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, J02.9 [Acute pharyngitis, unspecified]  ==> NEW",No,Insured,,,,,09-08-2022,09-08-2022,,,10,OPD,
10926,09-08-2022,"Odorkor
",72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ]",,pension,,09-08-2022,09-08-2022,,,10,OPD,
10930,09-08-2022,ABLEKUMA FAN MILK,88 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet ]",,,09-08-2022,09-08-2022,,,20,OPD,
10938,09-08-2022,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,09-08-2022,09-08-2022,,,10,OPD,
11271,09-08-2022,ODUMAN,50 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 7 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | Stat |  For 1 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]",,Retired,,09-08-2022,09-08-2022,,,60,OPD,
11341,09-08-2022,OBLOGO,61 Year(s),Male,,,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | BDS |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BDS |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ], ANTACID SUSPENSION 200MLS[ ANTACID  | 200ML | Suspension | TDS |  For 14 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], ANTACID SUSPENSION 200MLS[ ANTACID  | 200ML | Suspension ]",TRADER,,09-08-2022,09-08-2022,,,70,OPD,
11349,08-08-2022,old barrier,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,08-08-2022,08-08-2022,,,20,OPD,
11350,08-08-2022,dansomn,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Para Professional,,08-08-2022,08-08-2022,,,20,OPD,
11351,08-08-2022,TETEGU-JUNCTN NEW SITE,69 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,"H01.09 [Unspecified blepharitis unspecified eye, unspecified eyelid]  ==> NEW, E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD","I10. [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, M54.40 [Lumbago with sciatica, unspecified side]  ==> OLD",No,Insured,"OXYPOL EYE OINTMENT[ OXYPOL EYE OINTMENT | 10G | Ointment | BDS |  For 14 Days  ], NORMO TEARS EYE DROP[ HYDROMELLOSE | 10ML | Drops | QID |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",housewife,,08-08-2022,08-08-2022,,,20,OPD,
11352,08-08-2022,gbawe,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"R73.9 [Hyperglycaemia, unspecified]  ==> NEW, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,"RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], STUGERON TABLET 25MG[  | 25MG | Tablet | BID |  For 5 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], STUGERON TABLET 25MG[  | 25MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,08-08-2022,08-08-2022,,,10,OPD,
11355,08-08-2022,weija scc,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, J00. [Acute nasopharyngitis [common cold]]  ==> NEW, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW, F51.01 [Primary insomnia]  ==> NEW",No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 90 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TDS |  For 10 Days  ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository | PRN |  For 5 Days  ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution | PRN |  For 5 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,08-08-2022,08-08-2022,,,20,OPD,
11362,08-08-2022,GBAWE,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository | PRN |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository ]",,,08-08-2022,08-08-2022,,,10,OPD,
11370,08-08-2022,LAPAZ-NYAMKYE,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], DALACIN  C ()[ DALACIN  C |  |  | QID |  For 7 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DALACIN  C ()[ DALACIN  C |  |  ]",TRADER,,08-08-2022,08-08-2022,,,10,OPD,
11371,08-08-2022,kasoa,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,08-08-2022,08-08-2022,,,10,OPD,
11372,08-08-2022,KASOA,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],,,,08-08-2022,08-08-2022,,,20,OPD,MR-7A-F5-118
11373,08-08-2022,"KWASHIEMAN 
JAH LAB OPP",59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,08-08-2022,08-08-2022,,,25,OPD,
11374,08-08-2022,weija,62 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,08-08-2022,08-08-2022,,,10,OPD,
11431,08-08-2022,BORTIANO,58 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,N34.2 [Other urethritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 5 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,08-08-2022,08-08-2022,,,20,OPD,
11446,08-08-2022,"TUBA , BORTIANOR HILLS",56 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 1 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,ACCOUNTANT,,08-08-2022,08-08-2022,,,20,OPD,
11519,08-08-2022,kwashieman,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 90 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,08-08-2022,08-08-2022,,,20,OPD,
11524,08-08-2022,MALLAM ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], DALACIN  C ()[ DALACIN  C |  |  | QID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 90 Days  ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution | TDS |  For 5 Days  ], ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], DALACIN  C ()[ DALACIN  C |  |  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution ], ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection ]",,,08-08-2022,08-08-2022,,,20,OPD,
11629,08-08-2022,KASOA ADOM CITY,87 Year(s),Male,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,No,Insured,"DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | TDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule | QID |  For 7 Days  ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet | OD |  For 15 Days  ]","DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule ], ZINCOVIT TABLET[ ZINCOVIT |  | Tablet ]",,,08-08-2022,08-08-2022,,,10,OPD,
11833,08-08-2022,NYANYANU,68 Year(s),Male,,,,No Outcome,NA ,E11.649 [Type 2 diabetes mellitus with hypoglycemia without coma]  ==> NEW,,No,Insured,"RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | BDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | BDS |  For 1 Days  ], DEXTROSE INFUSION 10%[ DEXTROSE | 10% 500ML | Infusion | BDS |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BID |  For 1 Days  ]","RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], DEXTROSE INFUSION 10%[ DEXTROSE | 10% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ]",CARPENTER,,08-08-2022,08-08-2022,,,0,OPD,
11865,08-08-2022,BORTIANOR,68 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",Pensioner,,08-08-2022,08-08-2022,,,10,OPD,
11976,08-08-2022,"SWEDRU, YAABAMU",84 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,08-08-2022,08-08-2022,,,60,OPD,
12137,07-08-2022,TUBA-TOWN,80 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",Pensioner,,07-08-2022,07-08-2022,,,105,OPD,
12436,05-08-2022,MALLAM-MASALACHI,66 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E10.622 [Type 1 diabetes mellitus with other skin ulcer]  ==> NEW,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BDS |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | OD |  For 30 Days  ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution | Stat |  For 1 Days  ]","AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution ]",,,05-08-2022,05-08-2022,,,10,OPD,
12457,05-08-2022,sowutuom,47 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 30 Days  ]",,,,05-08-2022,05-08-2022,,,10,OPD,
12460,05-08-2022,ABLEKUMA   AGAPE,76 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]",,,,05-08-2022,05-08-2022,,,10,OPD,
12485,05-08-2022,"KASOA
OPEIKUMA",56 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ]",,,,05-08-2022,05-08-2022,,,10,OPD,
12506,05-08-2022,awoshie,73 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,05-08-2022,05-08-2022,,,0,OPD,
12869,05-08-2022,tuba,69 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ],CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ],,,05-08-2022,05-08-2022,,,95,OPD,
13036,04-08-2022,SANTA MARIA,58 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], BRIDELIA TEA[ HERBAL |  | Powder | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BRIDELIA TEA[ HERBAL |  | Powder ]",,,04-08-2022,04-08-2022,,,50,OPD,
13044,04-08-2022,"LAPAZ
FISHPOND",73 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"BRIDELIA TEA[ HERBAL |  | Powder | BDS |  For 14 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","BRIDELIA TEA[ HERBAL |  | Powder ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,04-08-2022,04-08-2022,,,50,OPD,
13120,04-08-2022,KASOA KABULEY JUNCTION,66 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,04-08-2022,04-08-2022,,,10,OPD,
13129,04-08-2022,ANYAA PALAS TOWN ,63 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,G59.0* [Diabetic mononeuropathy]  ==> NEW,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 14 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,SECURITY PERSONNEL,,04-08-2022,04-08-2022,,,10,OPD,
13214,04-08-2022,WEIJA-HIGT TENSON,51 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ],,,,04-08-2022,04-08-2022,,,145,OPD,
13226,03-08-2022,kasoa atea,79 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | PRN |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ]",,,03-08-2022,03-08-2022,,,20,OPD,
13311,03-08-2022,KASOA ,40 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",TRADER,,03-08-2022,03-08-2022,,,50,OPD,
13378,03-08-2022,gbawe cp,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,03-08-2022,03-08-2022,,,20,OPD,
13386,03-08-2022,SOWUTUOM,64 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,I12.9 [Hypertensive renal disease without renal failure]  ==> NEW,No,Insured,"RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 1 Days  ]","RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,03-08-2022,03-08-2022,,,60,OPD,
13388,03-08-2022,ablekuman,62 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD",No,Insured,,,,,03-08-2022,03-08-2022,,,10,OPD,
13446,03-08-2022,KASOA ,48 Year(s),Male,,,,No Outcome,NA ,E08.39 [Diabetes mellitus due to underlying condition with other diabetic ophthalmic complication]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,03-08-2022,03-08-2022,,,60,OPD,
13498,03-08-2022,scc,65 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]",,Self Employed,,03-08-2022,03-08-2022,,,20,OPD,
13903,02-08-2022,"osu
",59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | PRN |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",TRADER,,02-08-2022,02-08-2022,,,60,OPD,
13906,02-08-2022,"MALLAM , MASALACHI ",69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,02-08-2022,02-08-2022,,,10,OPD,
13908,02-08-2022,new bortianor,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | PRN |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,02-08-2022,02-08-2022,,,10,OPD,
13910,02-08-2022,kwashiman,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,02-08-2022,02-08-2022,,,20,OPD,
13925,02-08-2022,scc,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,02-08-2022,02-08-2022,,,10,OPD,
13930,02-08-2022,TETEGU-NEAR HOLY CROSS SCH,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, L02.432 [Carbuncle of left axilla]  ==> NEW",No,Insured,"FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 5 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,02-08-2022,02-08-2022,,,20,OPD,
13931,02-08-2022,bulemi top,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,02-08-2022,02-08-2022,,,20,OPD,
13932,02-08-2022,KASOA,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,02-08-2022,02-08-2022,,,10,OPD,
13948,02-08-2022,MALLAM,35 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-08-2022,02-08-2022,,,10,OPD,
13987,02-08-2022,KASOA-OCOLOMBA,55 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 14 Days  ],NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ],,,02-08-2022,02-08-2022,,,10,OPD,
14035,02-08-2022,kasoa american junction,23 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-08-2022,02-08-2022,,,20,OPD,
14040,02-08-2022,TABORA-ALHAJI,34 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",CASHIER,,02-08-2022,02-08-2022,,,85,OPD,
14125,02-08-2022,SANTA MARIA,48 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",TRADER,,02-08-2022,02-08-2022,,,20,OPD,
14186,02-08-2022,"gbawe
",71 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,02-08-2022,02-08-2022,,,0,OPD,
14296,02-08-2022,NEW BORTIANOR,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, R73.9 [Hyperglycaemia, unspecified]  ==> NEW",No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,02-08-2022,02-08-2022,,,10,OPD,
14327,02-08-2022,KWASHIEMAN,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], NAT B CAPSULES[ NAT B |  | Capsule ]",pension,,02-08-2022,02-08-2022,,,20,OPD,
14371,02-08-2022,KAI ME BRE,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"N34.1 [Nonspecific urethritis]  ==> NEW, K64.09 [Unspecified hemorrhoids]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 5 Days  ], SOOTHING AGENT+LOCAL ANESTHETIC+ STERIOD OINTMENT[ ANUSOL | 15G | Ointment | BID |  For 10 Days  ], PHLEBODIA TABLET 600MG[  | 600MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], SOOTHING AGENT+LOCAL ANESTHETIC+ STERIOD OINTMENT[ ANUSOL | 15G | Ointment ], PHLEBODIA TABLET 600MG[  | 600MG | Tablet ]",,,02-08-2022,02-08-2022,,,20,OPD,
14550,01-08-2022,kasoa,67 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,01-08-2022,01-08-2022,,,10,OPD,
14556,01-08-2022,APLAKU ,78 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,01-08-2022,01-08-2022,,,20,OPD,
14557,01-08-2022,AGAPE UP TWON,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",Para Professional,,01-08-2022,01-08-2022,,,20,OPD,
14558,01-08-2022,nwe aplaku,76 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 3 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Daily |  For 7 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",,,01-08-2022,01-08-2022,,,10,OPD,
14560,01-08-2022,awoshie market,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",TRADER,,01-08-2022,01-08-2022,,,20,OPD,
14561,01-08-2022,MC CARTHY DOWN,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,01-08-2022,01-08-2022,,,20,OPD,
14603,01-08-2022,"NEW BORTIANOR
LANE 2",53 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"M43.6 [Torticollis]  ==> NEW, K58.01 [Irritable bowel syndrome with constipation]  ==> NEW, K05.01 [Acute gingivitis, non-plaque induced]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], PREDNISOLONE TABLET 5MG[ PREDNISOLONE | 5MG | Tablet | Daily |  For 10 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 30 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]",,,,01-08-2022,01-08-2022,,,10,OPD,
14648,01-08-2022,TETEGIU,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], GILOBA[ GILOBA | 40MG | Capsule | Daily |  For 30 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], GILOBA[ GILOBA | 40MG | Capsule ]",,,01-08-2022,01-08-2022,,,10,OPD,
14768,01-08-2022,TWIFO MANPONG,89 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,,,,,01-08-2022,01-08-2022,,,10,OPD,
14774,01-08-2022,gbawe,58 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,01-08-2022,01-08-2022,,,0,OPD,
14777,01-08-2022,AWOSHIE,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,TRADER,,01-08-2022,01-08-2022,,,70,OPD,
14861,01-08-2022,MALLAM-POLICE,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,01-08-2022,01-08-2022,,,20,OPD,20137/19
14909,01-08-2022,mccarthy,57 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | BID |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,01-08-2022,01-08-2022,,,55,OPD,
14980,01-08-2022,new weija,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,01-08-2022,01-08-2022,,,0,OPD,
